Format

Send to

Choose Destination
Cancer Cell. 2012 Feb 14;21(2):140-2. doi: 10.1016/j.ccr.2012.01.014.

aSIRTing control over cancer stem cells.

Author information

1
Department of Pharmacology, University of California San Diego School of Medicine, La Jolla, CA 92093, USA.

Abstract

Cancer stem cells lie at the root of chronic myelogenous leukemia (CML) and mediate its continued growth. Their resistance to current therapies results in an inability to eradicate the disease. In this issue of Cancer Cell, Li et al. identify SIRT1 as a new target for eliminating CML cancer stem cells.

PMID:
22340585
DOI:
10.1016/j.ccr.2012.01.014
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center